Profile image
Scientia Professor

Scientia Professor Andrew Grulich

1998 PhD, University of New South Wales, Sydney, NSW.

1990 MSc (Epid), London School of Hygiene & Tropical Medicine, UK.

1986 MBBS, Adelaide University, South Australia.

 

Professional

1995 Fellow of the Australian Faculty of Public Health Medicine, Royal Australasian College of Physicians.

1988 Diploma in Obstetrics, Flinders Medical Centre, South Australia.

 

HIV Epidemiology and Prevention Program
Phone
+61 (2) 9385 0956
E-mail
agrulich@kirby.unsw.edu.au
Location
Level, 6, Wallace Wurth Building, , UNSW Sydney, , Kensington 2052

2018

2015-

University of New South Wales Peter Baume Public Health Impact Award for career achievement and excellence in public health and significant international public health impact

Fellow of the Australian Academy of Health and Medical Sciences

Andrew has held two NHMRC Principal Research Fellowships and currently holds an NHMRC Investigator grant (leadership level 3). In 2016-2020 he was named CI on grants totalling > $17million (>$56million in his career). Of these grants, in 2012-17 he was CIA on grants totalling $7.6million ($10.6million in his career). He has been successful as a CI in obtaining grants from the NHMRC (program, project, partnership schemes), Cancer Councils and Cure Cancer Australia, State and Federal Health Departments, the pharmaceutical industry, and international philanthropic organisations.

Key highlights include

1. HIV treatment as prevention in gay men: The Opposites Attract study of over 300 HIV-serodiscordant gay men is a key foundation stone of the international undetectable = untransmissible movement and is extensively referenced in international guidelines.  

Bavinton BR, Pinto AN, Phanuphak N, Grinsztejn B, Prestage GP, Zablotska-Manos IB, Jin F, Fairley CK, Moore R, Roth N, Bloch M, Pell C, McNulty AM, Baker D, Hoy J, Tee BK, Templeton DJ, Cooper DA, Emery S, Kelleher A, Grulich AE and The Opposites Attract Study Group. Viral suppression and HIV transmission in homosexual male serodiscordant couples: an international cohort study. Lancet HIV. 2018;5:e438-e447

 

2. Pre-exposure prophylaxis in homosexual men: the Expanded PrEP Implementation in Communities (NSW) study of close to 10,000 participants was one fo the first studies to demonstrate the population-level impact of PrEP. Grulich AE, Guy R, Amin J, Jin F, Selvey C, Holden J, Schmidt HMA, Zablotska I, Price K, Whittaker B, Chant K, Cooper C, McGill S, Telfer B, Yeung B, Levitt G, Ogilvie E, Dharan NJ, Hammoud MA, Vaccher S, Watchirs-Smith L, McNulty A, Smith DJ, Allen DM, Baker D, Bloch M, Bopage RI, Brown K, Carr A, Carmody CJ, Collins KL, Finlayson R, Foster R, Jackson EY, Lewis DA, Lusk J, O’Connor CC, Ryder N, Vlahakis E, Read P, Cooper DA, for the Expanded PrEP Implementation in Communities New South Wales (EPIC-NSW) research group. Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW study. Lancet HIV, 2018;5:e629-37i

3. The study of prevention of anal cancer (SPANC) was a 3-year cohort study of anal human papillomavirus infecion and related squamous intra-epithelial neoplasia in HIV-positive and HIV-negative homosexual men. 

Poynten IM, Jin F, Roberts JM, Templeton DJ, Law C, Cornall AM, Molano M, Machalek DA, Carr A, Farnsworth A, Tabrizi S, Phillips S, Fairley CK, Garland SM, Hillman RJ, Grulich AE on behalf of the Study of Prevention of Anal Cancer Study Team. The natural history of anal high-grade squamous intraepithelial lesions in gay and bisexual men. Clin Inf Diseases. 2021;72:853-861.

 

 

Epidemiology and prevention of HIV infection, including behavioural and biomedical prevention. Malignancies associated with HIV infection and other immunodeficient states and infections. HPV infection and anal cancer. Epidemiological methods.